Abstract:AIM Adenosine receptors and extracellular adenosine have been demonstrated to modulate vascular smooth muscle cell (VSMC) proliferation and neointima formation. Adenosine kinase (ADK) is a major enzyme regulating intracellular adenosine levels, but is function in VSMC remains unclear. Here, we investigated the role of ADK in vascular injury-induced smooth muscle proliferation and delineated the mechanisms underlying its action. METHODS AND RESULTS We found that ADK expression was higher in the neointima of injured vessels and in PDGF-treated VSMCs. Genetic and pharmacological inhibition of ADK was enough to attenuate arterial injury-induced neointima formation due to inhibition of VSMC proliferation. Mechanistically, using infinium methylation assays and bisulfite sequencing, we showed that ADK metabolized the intracellular adenosine and potentiated the transmethylation pathway, then induced the aberrant DNA hypermethylation. Pharmacological inhibition of aberrant DNA hypermethylation increased KLF4 expression and suppressed VSMC proliferation as well as the neointima formation. Importantly, in human femoral arteries, we observed increased ADK expression and DNA hypermethylation as well as decreased KLF4 expression in neointimal VSMCs of stenotic vessels suggesting that our findings in mice are relevant for human disease and may hold translational significance. CONCLUSIONS Our study unravels a novel mechanism by which ADK promotes VSMC proliferation via inducing aberrant DNA hypermethylation, thereby downregulating KLF4 expression and promoting neointima formation. These findings advance the possibility of targeting ADK as an epigenetic modulator to combat vascular injury. TRANSLATIONAL PERSPECTIVE Abnormal proliferation of vascular smooth muscle cell (VSMC) is key to abundant occlusive vascular diseases in humans, such as atherosclerosis and intimal hyperplasia associated with restenosis. Adenosine has been shown to combat abnormal smooth muscle proliferation. Here, we demonstrate that increased catabolism of adenosine by adenosine kinase (ADK) promotes abnormal VSMC proliferation. The pathological ADK overexpression in both mice and humans with vascular disease promotes VSMC proliferation via inducing aberrant DNA hypermethylation and KLF4 downregulation. Our study suggests that pharmacological augmentation of endogenous adenosine by targeting ADK represents a promising therapeutic strategy for occlusive vascular diseases.

Abstract 2074: De Novo Nucleotide Synthesis is Necessary for DNA Damage and Repair in Atheroprone Endothelial Cells

ATIC-Mediated De Novo Purine Synthesis Protects Endothelial Cells from Disturbed Flow-Induced Injury in Atherosclerosis

Phospholipid Biosynthesis Modulates Nucleotide Metabolism and Reductive Capacity

Characterization of the Molecular Mechanisms Underlying Increased Ischemic Damage in the Aldehyde Dehydrogenase 2 Genetic Polymorphism Using a Human Induced Pluripotent Stem Cell Model System.

Oxidized phospholipids regulate amino acid metabolism through MTHFD2 to facilitate nucleotide release in endothelial cells

Abstract 461: Enhanced Glycolysis in Endothelial Cells Protects Against Atherosclerosis

Abstract 11289: Suppression of <i>De Novo</i> Purine Synthesis Reduces Development and Progression of Pulmonary Hypertension in Rodent Models

DNMT1 Mediates the Disturbed Flow-Induced Endothelial to Mesenchymal Transition Through Disrupting Β-Alanine and Carnosine Homeostasis.

Abstract 139: Precision Nanomedicine Targeting Novel Endothelial Mechano-sensing Mechanisms To Treat Vascular Diseases

Fatty acid carbon is essential for dNTP synthesis in endothelial cells

Abstract 5808: Endothelial Cell Polyploidization Induces an Atherogenic Phenotype and is Prevented by Activating the Nampt-SIRT1 Axis

Abstract 701: Atherosclerosis Is A Smooth Muscle Cell-driven Tumor-like Disease

Epigenetic Mechanism in Regulation of Endothelial Function by Disturbed Flow: Induction of DNA Hypermethylation by DNMT1

Adenosine kinase is critical for neointima formation after vascular injury by inducing aberrant DNA hypermethylation.

Hemodynamic Disturbed Flow Induces Differential DNA Methylation of Endothelial Kruppel-Like Factor 4 Promoter in Vitro and in Vivo

Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells

The Mammalian Target Of Rapamycin And Dna Methyltransferase 1 Axis Mediates Vascular Endothelial Dysfunction In Response To Disturbed Flow

Endothelial Reprogramming by Disturbed Flow Revealed by Single-Cell RNA and Chromatin Accessibility Study

Therapeutic Targeting of Neutrophil Extracellular Traps in Atherogenic Inflammation

Emerging Topic: Flow-Related Epigenetic Regulation of Endothelial Phenotype Through DNA Methylation.

Abstract 5223: Dimethylarginine Dimethylaminohydrolase 1modulates Endothelial Cell Growth and Injury Repair Through No and Akt